Aardvark Therapeutics (AARD) shares debuted on Nasdaq Thursday with an opening price of $15.18, below the initial public offering price of $16.
The shares more recently were changing hands at roughly $14 apiece, further down 13%.
The stock debuted on the Nasdaq Global Market under the ticker symbol "AARD."
The IPO consists of 5.9 million shares to raise $94.2 million and the company has granted underwriters an option to buy up to an additional 883,200 shares.
Price: 13.87, Change: -2.13, Percent Change: -13.31
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。